Pradaxa 30 mg/1

Pradaxa 30 mg/1 is an oral pellet formulation of dabigatran etexilate, used for blood thinning and clot prevention. This medication is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc. in the USA.

Pradaxa 30 mg/1 is primarily used for blood thinning to prevent blood clots. It is often prescribed for conditions where reducing the risk of clot formation is crucial. The medication works by inhibiting certain clotting factors in the blood, helping to maintain blood flow and reduce the risk of stroke or heart attack. What is Pradaxa used for? It is commonly used in the management of atrial fibrillation and other conditions requiring anticoagulation therapy.

Common effects of Pradaxa 30 mg/1 may include bleeding more easily than usual. Some users might experience bruising, nosebleeds, or prolonged bleeding from cuts. It is important to monitor for any signs of unusual bleeding and consult a healthcare provider if such effects are observed.

Pradaxa 30 mg/1 should be handled with care, especially in individuals with a history of bleeding disorders or stomach ulcers. It is crucial to follow the prescribed dosage and administration instructions. Regular monitoring may be necessary to ensure the medication is working as intended and to avoid potential complications.

Pradaxa 30 mg/1 may interact with other medications, including certain pain relievers, anticoagulants, and antiplatelet drugs. Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always inform healthcare providers about all medications and supplements being taken to avoid potential interactions.